Mundipharma: all 120 studies

Page 1 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer PatientsNot yet recruitingNCT07869797
• Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsRecruitingNCT05835479Phase 2
• Tinostamustine Conditioning and Autologous Stem CellTerminatedNCT03687125Phase 1/2Results posted
• OTR Tablet 10 mg Fasted-state Bioequivalence StudyCompletedNCT03403504Phase 1Results posted
• OTR Tablet 40 mg Fed-state Bioequivalence StudyCompletedNCT03398330Phase 1Results posted
• OTR Tablet 40 mg Fasted-state Bioequivalence StudyCompletedNCT03398278Phase 1Results posted
• A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCLCompletedNCT03349333Phase 3Results posted
• Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.CompletedNCT03345485Phase 1/2Results posted
• OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant PatientsCompletedNCT02880475Phase 1Results posted
• Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure UlcerTerminatedNCT02863263Not applicableResults posted
• Analgesic Treatment for Cancer Pain in South East AsiaCompletedNCT02664987Results posted
• An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.CompletedNCT02660229Phase 4Results posted
• Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate IntensityCompletedNCT02519387Phase 4Results posted
• Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)CompletedNCT02072200Phase 4Results posted
• Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)CompletedNCT01983111Phase 4Results posted
• Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle PainCompletedNCT01961271Phase 4Results posted
• Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer PainCompletedNCT01885182Phase 3Results posted
• An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal DisordersCompletedNCT01818700Phase 4Results posted
• An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal DisordersCompletedNCT01811238Phase 4Results posted
• An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)CompletedNCT01811186Phase 4Results posted
• PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer PainCompletedNCT01719757Phase 4Results posted
• OxyNorm Capsules in Post-Operative Pain StudyCompletedNCT01675635Phase 3Results posted
• Immediate-Release Oxycodone Capsules Study in Cancer PainCompletedNCT01675622Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)CompletedNCT01675531Phase 4Results posted
• OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) StudyCompletedNCT01643772Phase 1Results posted
• A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer PatientsCompletedNCT01313780Phase 4Results posted
• OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee ArthroplastyCompletedNCT01083485Phase 4Results posted
• A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic PolyneuropathyCompletedNCT00944697Phase 2Results posted
• Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment OptionsActive, not recruitingNCT06794554Phase 2
• Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of AgeTerminatedNCT05534529Phase 1
• Study of Tinostamustine for Adjuvant Treatment of GlioblastomaCompletedNCT05432375Early Phase 1
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 3
• Safety and Effectiveness of Transdermal Buprenorphine in Cancer PainCompletedNCT04315831
• Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma PatientsWithdrawnNCT04271839Phase 4
• Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI TherapyTerminatedNCT04124510Phase 3
• Buprenorphine Transdermal Patches Pharmacokinetic StudyStatus unknownNCT03975010Phase 1
• A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer PainStatus unknownNCT03967327Phase 3
• Efficacy and Safety of Penthrox® Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With TraumaCompletedNCT03798899Phase 4
• Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs TreatmentCompletedNCT03768466Phase 4
• Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)CompletedNCT03585374Phase 3
• Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 YearsStatus unknownNCT03387241Phase 3
• The Effect of Skin Cleansers on the Skin Surface MicrobiomeCompletedNCT03348917Phase 4
• Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency UnitsCompletedNCT03256903Phase 3
• A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176199Phase 4
• Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176121Phase 4
• Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain PatientsStatus unknownNCT03155516Not applicable
• A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior TherapyStatus unknownNCT03150602Phase 4
• The Effect of Oral Antiseptic Gargles on the Oral Cavity MicrobiomeCompletedNCT03141554Phase 4
• Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.CompletedNCT03062644Phase 3
• Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib).CompletedNCT02982161Phase 3
• Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy SubjectsCompletedNCT02912377Phase 1
• Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.WithdrawnNCT02811315
• Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral SolutionCompletedNCT02773316Phase 1
• A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in AsthmaCompletedNCT02753712Phase 3
• Betafoam Diabetes Mellitus Foot StudyCompletedNCT02732886Not applicable
• A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated EosinophilsTerminatedNCT02693769Phase 2/3
• Burn Wound Management of Betafoam® and Allevyn® AgCompletedNCT02660541Not applicable
• Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy SubjectsCompletedNCT02629562Phase 1
• Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic MalignanciesCompletedNCT02576496Phase 1
• Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor SiteCompletedNCT02543034Not applicable
• Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/SalmeterolTerminatedNCT02491970Phase 4
• Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated PainCompletedNCT02452112Phase 2/3
• A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed MedicationCompletedNCT02446561Phase 1
• An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch AdhesionCompletedNCT02431624Phase 1
• A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy VolunteersCompletedNCT02403713Phase 1
• To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer PainCompletedNCT02321397Phase 2/3
• Bioequivalence and Adhesion Comparison of Buprenorphine PatchesCompletedNCT02268422Phase 1
• Flutiform® Compared With Seretide® in the Treatment of COPDCompletedNCT02195375Phase 2/3
• A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation PatchesCompletedNCT02160067Phase 1
• A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.CompletedNCT02133820Phase 1
• A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed MedicationCompletedNCT02089581Phase 1
• Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.CompletedNCT02063139Phase 2
• Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell LymphomaCompletedNCT02013362Phase 1/2
• A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant PainCompletedNCT01971632Phase 3
• A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).CompletedNCT01957046Phase 4
• A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPDCompletedNCT01946620Phase 3
• Targin for Non-cancer PainCompletedNCT01918098Phase 3
• A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal AspectsCompletedNCT01915147Phase 2
• A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMRTerminatedNCT01821040Phase 3
• Non-interventional Study Comparing Targiniq and Oxycodone/LaxativesCompletedNCT01812733
• Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma PatientsCompletedNCT01776411Phase 1/2
• A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)CompletedNCT01739387
• Norspan Transdermal Patches Study in Osteoarthritis PatientsCompletedNCT01643759Phase 1
• Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric PatientsCompletedNCT01511367Phase 3
• Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese PatientCompletedNCT01482936Phase 1
• NORSPAN Transdermal Patches Phase III Study In Non-Cancer PainCompletedNCT01476774Phase 3
• Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose CombinationsCompletedNCT01449123Phase 4
• A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainCompletedNCT01439100Phase 3
• A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer TherapyCompletedNCT01438567Phase 3
• Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving TreatmentCompletedNCT01304134Phase 3
• A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.TerminatedNCT01289223Phase 3
• Norspan Efficacy and Safety Among Elderly SubjectsCompletedNCT01276431Phase 4
• Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UKCompletedNCT01225861
• OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)CompletedNCT01197261Phase 2
• Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167699Phase 3
• Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant PainCompletedNCT01167127Phase 3
• Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime SymptomsCompletedNCT01112644Phase 3
• Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible AsthmaCompletedNCT01099722Phase 3
• Morphine Slow-release Capsules in Substitution TherapyCompletedNCT01079117Phase 3
• A Study Comparing Norspan Patch and Oral TramadolCompletedNCT01019265Phase 4

← Mundipharma overview and focus areas